Netherlands· NL-1f3510c17adb
Zure oordruppels met triamcinolonacetonide DMB 0,1% FNA, oordruppels, oplossing 1 mg/g triamcinolonacetonide
A triamcinolon und antiinfektiva product containing triamcinolonacetonide, registered in Netherlands by Tiofarma B.V..
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TRIAMCINOLONACETONIDE
- Manufacturer
- Tiofarma B.V.
- Country
- Netherlands (NL)
- ATC code
- S02CA04
- ATC class
- Triamcinolon und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id33246
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triamcinolon und antiinfektiva in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States24 Hour Nasal AllergyMeijer Distribution Inc
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- FinlandAftabMeda Oy
- Japanトリアムシノロンアセトニドブリストル・マイヤーズ スクイブ
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a1413d5-7e63-436d-90b4-0dc948fa871b GET /v1/drugs/2a1413d5-7e63-436d-90b4-0dc948fa871b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oordruppels, oplossing",
"route": "Auriculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33246_smpc.pdf",
"strength": null,
"atc_label": "Triamcinolone And Antiinfectives",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg33246",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"PROPYLEENGLYCOL (E 1520)",
"WATER, GEZUIVERD"
],
"substances": [
"TRIAMCINOLONACETONIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h33246.pdf",
"authorised_at": "2010/09/09",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "33246",
"additional_monitoring": "N"
}See everything about triamcinolon und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.